Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 4—April 2002
Research

Invasive Group A Streptococcal Infections, Israel

Allon E. Moses*Comments to Author , Sara Goldberg†, Zinaida Korenman‡, Miriam Ravins†, Emanuel Hanski†, Mervyn Shapiro*, and the Israeli Groupfor the Study of Infections Caused by Streptococcus pyogenes1
Author affiliations: *Hadassah University Medical Center, Jerusalem, Israel; †Hebrew University Medical School, Jerusalem, Israel; ‡Ministry of Health Streptococcal Reference Laboratory, Jerusalem, Israel;

Main Article

Table 2

Clinical characteristics of invasive GAS infections: comparison of the national cohort to the Jerusalem cohort, 1997–1998

Disease National cohort % Jerusalem cohort %
Soft tissue infectiona 272 67 88 66
Primary bacteremia 57 14 11 8.3
Pneumonia 14 3.4 4 3
Postpartum 10 2.4 6 4.5
Arthritis 8 2 1 < 1%
Lymphadenitis 6 1.5 2 1.5
Chickenpox 5 1.2 5 3.8
Meningitis 5 1.2 2 1.5
Peritonitis 5 1.2 4 3
PID 5 1.2 1 < 1%
Osteomyelitis 4 < 1% 2 1.5
Others 14 3.4 5 3.8
Unknown 4 < 1%
Total 409 100 133 100

aSoft tissue infection includes 35 patients with abscesses, 14 with necrotizing fasciitis, and 10 with burns. PID = pelvic inflammatory disease.

Main Article

1Israeli Group for the Study of Infections Caused by Streptococcus pyogenes: V. Agmon, A. Mates, Ministry of Health Streptococcal Reference Laboratory; E. Ambun, Barzilai Hospital, Ashkelon; E. Azam, French Hospital, Nazareth; S. Berger, Y. Igra, Ichilov Medical Center, Tel Aviv; I. Boldur, A. Itzhaki, Assaf Haroffe Hospital, Zriffin; N. Chashan, R. Finkelstein, Ramban Hospital, Haifa; Y. Glick, Laniado Hospital, Natanya; R. Gutman, M. Dan, Wolfson Medical Center, Holon; E. Halperin, Bikur Cholim Hospital, Jerusalem; M. Kaupstein, D. Chasin, Hillel Yaffe Hospital, Hedera; N. Keller, Sheba Medical Center, Tel Hashomer; R. Kolodney, R. Raz, Haemek Hospital, Afula; A. Lefler, Naharia Hospital; D. Lev, M. Efros, Carmel Hospital, Haifa; A. Linben, Poryia Hospital, Tiberias; M. Maayan, M. Chovers, Meir Hospital, Kfar Saba; A. Miskin, Z. Landau, Kaplan Hospital, Rehovot; I. Moskovitz, Hasharon Hospital, Petah Tiqva; G. Rahav, D. Engelstein, Hadassah Medical Center, Jerusalem; Z. Samra, A. Bushara, Rabin Medical Center, Petah Tiqva; I. Sarugo, I. Potesman, Bnei Zion Hospital, Haifa; Y. Schlezinger, B. Rodensky, D. Atias, Share Zedek Hospital, Jerusalem; M. Shechter, Ziv Hospital, Zafat; and P. Yagupsky, Soroka Medical Center, Beer Sheva

Page created: July 15, 2010
Page updated: July 15, 2010
Page reviewed: July 15, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external